Risk Factors of Local Oropharyngeal and Laryngeal Adverse Effects from Use of Single Inhaled Corticosteroids and Long-Acting Beta-Agonists

Risk Factors of Local Oropharyngeal and Laryngeal Adverse Effects from Use of Single Inhaled Corticosteroids and Long-Acting Beta-Agonists

Background: : Single inhaled corticosteroids and long-acting beta-agonists (ICS/LABA) are clinically effective and safe. However, if local oropharyngeal and laryngeal adverse effects (LOLAE) appear, adherence to the use of ICS is impaired. To minimize the development of adverse effects, it is essent...

Full description

Bibliographic Details
Main Authors: Nobuyuki Horita, Masako To, Kosuke Araki, Kosuke Haruki, Yasuo To
Format: Article
Language:English
Published: Elsevier 2012-01-01
Series:Allergology International
Subjects:
adrenergic beta-agonists
adverse effects
asthma
glucocorticoids
metered-dose inhalers
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015302598

Similar Items

Similar Items